NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
February 15, 2005 • Volume 2 / Number 7 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

Featured Article

NCI Announces Senior Leadership Changes

Speaking at an "all-hands" meeting of National Cancer Institute (NCI) employees today, NCI Director Dr. Andrew C. von Eschenbach announced several changes among senior NCI leadership, including the departures of a deputy director and the director of the Center for Cancer Research (CCR).

Dr. Karen H. Antman, the deputy director for translational and clinical sciences, has accepted a job as provost of the Boston University Medical Campus and dean of the School of Medicine. And CCR Director Dr. J. Carl Barrett has taken a position with the Novartis Institutes for Biomedical Research as Global Head of Oncology Biomarkers.

"Losing these two individuals with respect to their leadership is, for us, going to be a great loss," Dr. von Eschenbach said. "But, like all great institutions, we have great people who step up." CCR Principal Deputy Director Dr. Robert Wiltrout, he announced, will become the new director of CCR.  Read more  

Director's Update

CTWG to Unveil Draft Proposal and Invite Continuing Input at NCAB

The Clinical Trials Working Group (CTWG), a panel of 40 clinical trialists, advocates, and government representatives established in 2004 by NCI Director Dr. Andrew C. von Eschenbach to evaluate the national cancer clinical research enterprise, will report draft recommendations to the National Cancer Advisory Board (NCAB) this week.

As part of its transparent, inclusive approach to increasing cancer clinical trials efficiency, decreasing redundancy and administrative burdens, and better coordinating activities to enhance the development and delivery of the best therapies to people with cancer, CTWG welcomes public comment on the draft recommendations. Final  Read more  

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at